AAAAAA
Results:
1-18
|
Results: 18
Authors:
Nurden, P
Citation: P. Nurden, The anti-GPIIb-IIIa, TRANSF CL B, 8(2), 2001, pp. 114-122
Authors:
Nurden, P
Nurden, A
Citation: P. Nurden et A. Nurden, A new platelet ADP receptor targeted by antithrombotic drugs, M S-MED SCI, 17(6-7), 2001, pp. 787-788
Authors:
Hollopeter, G
Jantzen, HM
Vincent, D
Li, G
England, L
Ramakrishnan, V
Yang, RB
Nurden, P
Nurden, A
Julius, D
Conley, PB
Citation: G. Hollopeter et al., Identification of the platelet ADP receptor targeted by antithrombotic drugs, NATURE, 409(6817), 2001, pp. 202-207
Authors:
Ruiz, C
Liu, CY
Sun, QH
Sigaud-Fiks, M
Fressinaud, E
Muller, JY
Nurden, P
Nurden, AT
Newman, PJ
Valentin, N
Citation: C. Ruiz et al., A point mutation in the cysteine-rich domain of glycoprotein (GP) IIIa results in the expression of a GPIIb-IIIa (alpha IIb beta 3) integrin receptorlocked in a high-affinity state and a Glanzmann thrombasthenia-like phenotype, BLOOD, 98(8), 2001, pp. 2432-2441
Authors:
Furman, MI
Nurden, P
Berndt, MC
Nurden, AT
Benoit, SE
Barnard, MR
Ofosu, FA
Michelson, AD
Citation: Mi. Furman et al., The cleaved peptide of PAR1 results in a redistribution of the platelet surface GPIb-IX-V complex to the surface-connected canalicular system, THROMB HAEM, 84(5), 2000, pp. 897-903
Authors:
Poujol, C
Ramakrishnan, V
DeGuzman, F
Nurden, AT
Phillips, DR
Nurden, P
Citation: C. Poujol et al., Ultrastructural analysis of megakaryocytes in GPV knockout mice, THROMB HAEM, 84(2), 2000, pp. 312-318
Authors:
d'Oiron, R
Menart, C
Trzeciak, MC
Nurden, P
Fressinaud, E
Dreyfus, M
Laurian, Y
Negrier, C
Citation: R. D'Oiron et al., Use of recombinant factor VIIa in 3 patients with inherited type I Glanzmann's thrombasthenia undergoing inversive procedures, THROMB HAEM, 83(5), 2000, pp. 644-647
Authors:
Vatan, R
Delpeu, K
Vergnes, C
Constans, J
Le Bougeant, P
Nurden, P
Roudaut, MF
Boisseau, M
Le Metayer, P
Morlat, P
Longy-Boursier, M
Le Bras, M
Beylot, J
Midy, D
Baste, JC
Conri, C
Citation: R. Vatan et al., Clinico-biological study in 100 symptomatic patients with factor V Leiden mutation, REV MED IN, 21(5), 2000, pp. 465
Authors:
Nurden, P
Chretien, F
Poujol, C
Winckler, J
Borel-Derlon, A
Citation: P. Nurden et al., Platelet ultrastructural abnormalities in three patients with type 2B von Willebrand disease, BR J HAEM, 110(3), 2000, pp. 704-714
Authors:
Roux, DTL
Roullot, V
Poujol, C
Kortulewski, T
Nurden, P
Marguerie, G
Citation: Dtl. Roux et al., Thrombasthenic mice generated by replacement of the integrin alpha(IIb) gene: demonstration that transcriptional activation of this megakaryocytic locus precedes lineage commitment, BLOOD, 96(4), 2000, pp. 1399-1408
Expression of markers of platelet activation and the interpatient variation in response to abciximab
Authors:
Bihour, C
Durrieu-Jais, C
Macchi, L
Poujol, C
Coste, P
Besse, P
Nurden, P
Nurden, AT
Citation: C. Bihour et al., Expression of markers of platelet activation and the interpatient variation in response to abciximab, ART THROM V, 19(2), 1999, pp. 212-219
Authors:
Nurden, AT
Poujol, C
Durrieu-Jais, C
Nurden, P
Citation: At. Nurden et al., Platelet glycoprotein IIb/IIIa inhibitors - Basic and clinical aspects, ART THROM V, 19(12), 1999, pp. 2835-2840
Authors:
Coiffic, A
Cazes, E
Janvier, G
Forestier, F
Lanza, F
Nurden, A
Nurden, P
Citation: A. Coiffic et al., Inhibition of platelet aggregation by abciximab but not by aspirin can be detected by a new point-of-care test, the hemostatus, THROMB RES, 95(2), 1999, pp. 83-91
Authors:
Poujol, C
Durrieu-Jais, C
Larrue, B
Nurden, AT
Nurden, P
Citation: C. Poujol et al., Accessibility of abciximab to megakaryocytes and endothelial cells in the bone marrow compartment: studies on a patient receiving antithrombotic therapy, BR J HAEM, 107(3), 1999, pp. 526-531
Authors:
Viallard, JF
Pellegrin, JL
Vergnes, C
Borel-Derlon, A
Clofent-Sanchez, G
Nurden, AT
Leng, B
Nurden, P
Citation: Jf. Viallard et al., Three cases of acquired von Willebrand disease associated with systemic lupus erythematosus, BR J HAEM, 105(2), 1999, pp. 532-537
Authors:
Nurden, P
Poujol, C
Durrieu-Jais, C
Winckler, J
Combrie, R
Macchi, L
Bihour, C
Wagner, C
Jordan, R
Nurden, AT
Citation: P. Nurden et al., Labeling of the internal pool of GP IIb-IIIa in platelets by c7E3 Fab fragments (abciximab): Flow and endocytic mechanisms contribute to the transport, BLOOD, 93(5), 1999, pp. 1622-1633
Authors:
Cazes, E
Nurden, P
Nurden, AT
Citation: E. Cazes et al., Abciximab binding to glycoprotein IIb-IIIa and protein tyrosine phosphorylation in human platelets, BLOOD, 93(11), 1999, pp. 4019-4020
Authors:
Poujol, C
Nurden, A
Paponneau, A
Heilmann, E
Nurden, P
Citation: C. Poujol et al., Ultrastructural analysis of the distribution of von Willebrand factor and fibrinogen in platelet aggregates formed in the PFA-100 (TM), PLATELETS, 9(6), 1998, pp. 381-389
Risultati:
1-18
|